Experiments for taxon Pteleopsis hylodendron (COMBRETACEAE)

30 experiments

Experiment	Worktypes	Pharmacology	Organism (specimen)	Compound
268763	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIBACTERIAL ACTIVITY	Pteleopsis hylodendron (COMBRETACEAE)	ELLAGIC ACID,3-3'-DI-O-METHYL:
268754	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIBACTERIAL ACTIVITY	Pteleopsis hylodendron (COMBRETACEAE)	ELLAGIC ACID,3-4-METHYLENEDIOXY-3'-O-METHYL:
248663	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIBACTERIAL ACTIVITY	Pteleopsis hylodendron (COMBRETACEAE)	OLEAN-12-EN-28-O-BETA-D-GALACTOSIDE,2-ALPHA-3-ALPHA-19-ALPHA-23-TETRAHYDROXY:
248657	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Pteleopsis hylodendron (COMBRETACEAE)	OLEAN-12-EN-28-O-BETA-D-GALACTOSIDE,2-ALPHA-3-ALPHA-19-ALPHA-23-TETRAHYDROXY:
268747	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIBACTERIAL ACTIVITY	Pteleopsis hylodendron (COMBRETACEAE)	ELLAGIC ACID,3-4-METHYLENEDIOXY-3'-O-METHYL: 4'-O-BETA-D-GLUCOSIDE
268764	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Pteleopsis hylodendron (COMBRETACEAE)	ELLAGIC ACID,3-3'-4'-TRI-O-METHYL:
268758	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Pteleopsis hylodendron (COMBRETACEAE)	ELLAGIC ACID,3-3'-DI-O-METHYL:
268753	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIBACTERIAL ACTIVITY	Pteleopsis hylodendron (COMBRETACEAE)	ELLAGIC ACID,3-4-METHYLENEDIOXY-3'-O-METHYL:
268755	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIBACTERIAL ACTIVITY	Pteleopsis hylodendron (COMBRETACEAE)	ELLAGIC ACID,3-4-METHYLENEDIOXY-3'-O-METHYL:
248662	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIBACTERIAL ACTIVITY	Pteleopsis hylodendron (COMBRETACEAE)	OLEAN-12-EN-28-O-BETA-D-GALACTOSIDE,2-ALPHA-3-ALPHA-19-ALPHA-23-TETRAHYDROXY:
268751	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIBACTERIAL ACTIVITY	Pteleopsis hylodendron (COMBRETACEAE)	PTELEOELLAGIC ACID DERIVATIVE
268762	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIBACTERIAL ACTIVITY	Pteleopsis hylodendron (COMBRETACEAE)	ELLAGIC ACID,3-3'-DI-O-METHYL:
248666	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Pteleopsis hylodendron (COMBRETACEAE)	OLEAN-12-EN-28-OIC ACID,2-ALPHA-3-BETA-21-BETA-23-TETRAHYDROXY:
268748	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIBACTERIAL ACTIVITY	Pteleopsis hylodendron (COMBRETACEAE)	ELLAGIC ACID,3-4-METHYLENEDIOXY-3'-O-METHYL: 4'-O-BETA-D-GLUCOSIDE
268759	PHARMACOLOGY OF COMPOUND - IN VITRO	RADICAL SCAVENGING EFFECT	Pteleopsis hylodendron (COMBRETACEAE)	ELLAGIC ACID,3-3'-DI-O-METHYL:
268752	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Pteleopsis hylodendron (COMBRETACEAE)	ELLAGIC ACID,3-4-METHYLENEDIOXY-3'-O-METHYL:
248661	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIBACTERIAL ACTIVITY	Pteleopsis hylodendron (COMBRETACEAE)	OLEAN-12-EN-28-O-BETA-D-GALACTOSIDE,2-ALPHA-3-ALPHA-19-ALPHA-23-TETRAHYDROXY:
268749	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Pteleopsis hylodendron (COMBRETACEAE)	PTELEOELLAGIC ACID DERIVATIVE
268745	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Pteleopsis hylodendron (COMBRETACEAE)	ELLAGIC ACID,3-4-METHYLENEDIOXY-3'-O-METHYL: 4'-O-BETA-D-GLUCOSIDE
268750	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIBACTERIAL ACTIVITY	Pteleopsis hylodendron (COMBRETACEAE)	PTELEOELLAGIC ACID DERIVATIVE
268761	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIBACTERIAL ACTIVITY	Pteleopsis hylodendron (COMBRETACEAE)	ELLAGIC ACID,3-3'-DI-O-METHYL:
268756	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIBACTERIAL ACTIVITY	Pteleopsis hylodendron (COMBRETACEAE)	ELLAGIC ACID,3-4-METHYLENEDIOXY-3'-O-METHYL:
248658	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIBACTERIAL ACTIVITY	Pteleopsis hylodendron (COMBRETACEAE)
248665	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Pteleopsis hylodendron (COMBRETACEAE)	SITOSTEROL-ALPHA(1-3)-DIGLUCOSIDE
268757	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIBACTERIAL ACTIVITY	Pteleopsis hylodendron (COMBRETACEAE)	ELLAGIC ACID,3-4-METHYLENEDIOXY-3'-O-METHYL:
268746	PHARMACOLOGY OF COMPOUND - IN VITRO	RADICAL SCAVENGING EFFECT	Pteleopsis hylodendron (COMBRETACEAE)	ELLAGIC ACID,3-4-METHYLENEDIOXY-3'-O-METHYL: 4'-O-BETA-D-GLUCOSIDE
248659	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIBACTERIAL ACTIVITY	Pteleopsis hylodendron (COMBRETACEAE)
268760	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIBACTERIAL ACTIVITY	Pteleopsis hylodendron (COMBRETACEAE)	ELLAGIC ACID,3-3'-DI-O-METHYL:
248664	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIBACTERIAL ACTIVITY	Pteleopsis hylodendron (COMBRETACEAE)	OLEAN-12-EN-28-O-BETA-D-GALACTOSIDE,2-ALPHA-3-ALPHA-19-ALPHA-23-TETRAHYDROXY:
248660	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIBACTERIAL ACTIVITY	Pteleopsis hylodendron (COMBRETACEAE)

Experiments for taxon Pteleopsis hylodendron (COMBRETACEAE)

Experiments (30 results)

Filters

Worktypes (11)

Pharmacology (3)

Compounds (9)

Organisms (2)